KEMIFARMA Consulting ApS: Financial statements 2020
CVR: 34709955
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
KEMIFARMA Consulting ApS (CVR 34709955) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -14,663 and a net result of DKK 392,334 compared with DKK 176,373 the year before. Equity in the 2020 report amounted to DKK 2,788,822. The solvency ratio was 96.3%.
- Gross Profit
- DKK -14,663
- Profit/Loss
- DKK 392,334
- Equity
- DKK 2,788,822
- Total Assets
- DKK 2,896,677
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -15K | 392K | 2.8M | - |
| 2019 | - | -32K | 176K | 2.4M | - |
| 2018 | - | -23K | -79K | 2.3M | - |
| 2017 | - | -11K | 191K | 2.4M | - |
| 2016 | - | -13K | 4K | 2.3M | - |
Official annual report
How creditworthy is KEMIFARMA Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
KEMIFARMA Consulting ApS has published its annual report for 2019. Gross profit came to DKK -31,977, and the net result was DKK 176,373.
About KEMIFARMA Consulting ApS
KEMIFARMA Consulting ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named KEMIFARMA HOLDING ApS. The management consists of Christian Hede-Andersen. The company is owned by Christian Hede-Andersen. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -57,469 and a net result of DKK 541,385 compared with DKK -378,700 the year before. Equity in the 2025 report amounted to DKK 3,414,022.